Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-93,500
Closed -$95.6M 74
2024
Q2
$95.6M Buy
93,500
+79,500
+568% +$76.4M 3.28% 5
2024
Q1
$13.6M Buy
+14,000
New +$12.4M 0.43% 52
2022
Q4
Sell
-52,500
Closed -$22.8M 42
2022
Q3
$22.8M Sell
52,500
-35,000
-40% -$17.5M 1.23% 23
2022
Q2
$41.6M Sell
87,500
-2,500
-3% -$1.4M 3.67% 6
2022
Q1
$60.1M Buy
90,000
+32,000
+55% +$21.4M 1.84% 15
2021
Q4
$46.2M Buy
+58,000
New +$46.1M 1.69% 21
2018
Q1
Sell
-150,000
Closed -$26.1M 134
2017
Q4
$26.1M Buy
150,000
+50,000
+50% +$8.82M 0.57% 47
2017
Q3
$17.1M Buy
+100,000
New +$15.3M 0.34% 64

Other funds holding ASML

Maplelane Capital's ASML Position: Q1 2026 in Review

Maplelane Capital reduced its ASML (ASML) stake by 45% in Q1 2026, selling an estimated $17.1M and leaving 15,000 shares worth $19.8M. The position accounts for 0.71% of the portfolio, ranked #41.

Maplelane Capital first reported a position in ASML in Q2 2014 and has held it in 11 quarters since. The position peaked at $95.5M in Q2 2024. 2,188 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

  • Maplelane Capital held 15,000 shares of ASML worth $19.8M as of Q1 2026.
  • Maplelane Capital sold 12,500 ASML shares in Q1 2026, an estimated $17.1M.
  • ASML made up 0.71% of Maplelane Capital's portfolio in Q1 2026, its #41 holding.
  • Maplelane Capital first reported a position in ASML in Q2 2014 and has held it in 11 quarters since.
  • Maplelane Capital's ASML position peaked at $95.5M in Q2 2024.
  • 2,188 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on Maplelane Capital's 13F filing for Q1 2026, filed 14 May 2026.